Concepedia
Statistics
Publications
8
Citations
969
H-Index
Active since
2013
Affiliations
Edinburgh Cancer Research(Current)
University of Edinburgh
Institute of Genetics and Cancer
Jason T. Weiss is an author at Edinburgh Cancer Research specializing in medicine, drug discovery, and pharmacology.
Top concepts
MedicinePharmacologyDrug DiscoveryBiochemistryNatural SciencesMedicinal ChemistryCell BiologyDrug DevelopmentRadiation OncologyBioorganic Chemistry
Publications per year
2013–2020
Extracellular palladium-catalysed dealkylation of 5-fluoro-1-propargyl-uracil as a bioorthogonally activated prodrug approach
Jason T. Weiss, John C. Dawson, Kenneth G. MacLeod et al. · Nature Communications · 2014 · 341 citations · Full text
Development and Bioorthogonal Activation of Palladium-Labile Prodrugs of Gemcitabine
Jason T. Weiss, John C. Dawson, Craig Fraser et al. · Journal of Medicinal Chemistry · 2014 · 197 citations · Full text
Pharmaceutical Science, Bioorganic Chemistry, Bioorthogonal Chemistry +16
A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal
Alessia Gagliardi, Nicholas P. Mullin, Zi Ying Tan et al. · The EMBO Journal · 2013 · 137 citations · Full text
Induced Pluripotent Stem Cell, Developmental Biology, Medicine +7
Efficient Palladium-Triggered Release of Vorinostat from a Bioorthogonal Precursor
Belén Rubio‐Ruíz, Jason T. Weiss, Asier Unciti‐Broceta · Journal of Medicinal Chemistry · 2016 · 108 citations · Full text
Medicinal Chemistry, Bioorganic Chemistry, Biochemistry +15
Palladium-Mediated Dealkylation of N-Propargyl-Floxuridine as a Bioorthogonal Oxygen-Independent Prodrug Strategy
Jason T. Weiss, Neil O. Carragher, Asier Unciti‐Broceta · Scientific Reports · 2015 · 70 citations · Full text
1–5 of 8